Pharmaceuticals giant GlaxoSmithKline considered bringing its own e-cigarettes to market but decided the category is “just too controversial”, its CEO has said.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.